First HOME monitor for patients on warfarin (Coumadin)

April 1997

The FDA just approved the first HOME monitor for patients on warfarin (Coumadin)...ProTime Microcoagulation System from International Technidyne.

The CoaguChek by Boehringer Mannheim will be next.

These monitors are already being used in anticoagulation clinics. They are fingerstick tests...similar to blood glucose tests.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

IMPROVING QUALITY
Cardiology New drug for hypertension, Diovan (valsartan)
Cardiology Using Cozaar (losartan) for heart failure
Cardiology Whether digoxin really is useful for patients with heart failure
Interactions Drugs that interact with grapefruit
Dermatology Retin-A Micro, a new tretinoin gel for acne
Dermatology Proscar (finasteride) stimulating hair growth
Infectious Diseases Monurol (fosfomycin), a SINGLE dose antibiotic for bladder infections
Infectious Diseases Zagam (sparfloxacin), a new quinolone antibiotic
Infectious Diseases Sporanox (itraconazole) ORAL SOLUTION
Infectious Diseases Viracept (nelfinavir) for treating HIV in both children and adults
Osteoporosis Fosamax (alendronate) to be promoted to PREVENT osteoporosis
Osteoporosis New drug to inhibit bone loss called Skelid (SKEL-id, tiludronate)
Anticoagulants First HOME monitor for patients on warfarin (Coumadin)
Women's Health New estrogen patches will be hitting the market
Women's Health Vagistat-1 (tioconazole) ointment is now approved for OTC use
Asthma New asthma guidelines
Asthma Too many asthmatics still AREN'T using inhaled steroids
Cholesterol Cholestin, a new dietary supplement to lower cholesterol

First HOME monitor for patients on warfarin (Coumadin)

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents